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Background: Colorectal cancer is one of the most common cancers worldwide and its incidence is reported to be
increasing in resource-limited countries, probably due to the acquisition of a western lifestyle. However, information
regarding colorectal cancer in Tanzania and the study area in particular is limited. This study was conducted in our
local setting to describe the clinicopathological pattern of colorectal cancer and highlight the challenging problem
in the management of this disease.
Methods: This was a retrospective study of histologically confirmed cases of colorectal cancer seen at Bugando
Medical Center between July 2006 and June 2011. Data were retrieved from patients’ files and analyzed using SPSS
computer software version 17.0.
Results: A total of 332 colorectal cancer patients were enrolled in the study, representing 4.7% of all malignancies.
Males outnumbered females by a ratio of 1.6:1. The median age of patients at presentation was 46 years. The
majority of patients (96.7%) presented late with advanced stages. Lymph node and distant metastasis at the time of
diagnosis was recorded in 30.4% and 24.7% of cases, respectively. The rectosigmoid region was the most frequent
anatomical site (54.8%) involved and adenocarcinoma (98.8%) was the most common histopathological type. The
majority of adenocarcinomas (56.4%) were moderately differentiated. Mucinous and signet ring carcinomas
accounted for 38 (11.6%)and 15 (4.6%) patients, respectively. Three hundred and twenty-six (98.2%) patients
underwent surgical procedures for colorectal cancer. Only 54 out of 321 (16.8%) patients received adjuvant
treatment. Postoperative complication and mortality rates were 26.2% and 10.5%, respectively. The overall median
duration of hospital stay was 12 days. Only nine out of 297 survivors (3.0%) were available for follow-up at the end
of 5 years. Cancer recurrence was reported in 56 of 297 survivors (18.9%). Data on long-term survival were not
available as the majority of patients were lost to follow-up.
Conclusions: Colorectal cancer is not uncommon in our environment and shows a trend towards a relative young
age at diagnosis and the majority of patients present late with advanced stage. There is a need for screening of
high-risk populations, early diagnosis and effective cost-effective treatment and follow-up to improve outcome of
these patients.
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Colorectal cancer constitutes a major public health issue
globally with an estimated 1.2 million new cancer cases
and over 630,000 cancer deaths per year, almost 8% of
all cancer deaths [1,2]. It is the fourth most common
cancer in men and the third most common in women
worldwide [2]. Globally, the incidence of colorectal can-
cer varies widely by over 10-fold, with the highest inci-
dence rates in Australia and New Zealand, Europe and
North America, and the lowest rates in Africa and Asia
[1,3,4]. These geographic differences appear to be attrib-
utable to differences in dietary and environmental expo-
sures that are imposed upon a background of genetically
determined susceptibility [4]. However, despite this vari-
ation, the molecular characteristics remain similar
throughout the world [5,6]. While recent studies have
shown that the incidence of colorectal cancer is increas-
ing in sub-Saharan Africa, especially in the urban centers
[7,8], the converse is true in the developed world where
the incidence of colorectal cancer is declining with a
relatively good outcome of treatment attributable to
early detection, especially in high-risk individuals due to
widespread screening of the susceptible population, early
presentation, and advances in diagnostic tools and treat-
ment modalities [9].
The clinicopathological patterns of colorectal cancer
have been reported to vary in different geographical re-
gions. While in the western world colorectal cancer is a
disease of older patients, with most being diagnosed
after the age of 50 years [3,4,10], colorectal cancer in
African population tends to present at a young age with
advanced aggressive disease and associated poor progno-
sis [11-14].
The clinical stage of the disease at diagnosis often de-
termines the prognosis and survival rate of a patient
with colorectal cancer, with the best outcomes seen in
patients diagnosed at an early stage. However, the out-
come of treatment of colorectal cancer in our environ-
ment has been poor because the majority of these
patients present late to the hospital with advanced stage
and only palliative care is possible [10-14]. This is partly
due to paucity of local data regarding this condition and
lack of community awareness on the importance of early
reporting to hospital for early diagnosis and treatment.
Colorectal cancer and its treatment constitute a great
diagnostic and therapeutic challenge in resource-limited
countries such as Tanzania. Late presentation of the dis-
ease, lack of an adequate screening program, lack of
endoscopic facilities, lack of adjuvant therapy and a high
morbidity and mortality are among the hallmarks of the
disease in these countries [5,11-15].
The current treatment options of colorectal cancer
consist of surgery for early-stage disease and the com-
bination of surgery and adjuvant therapy for advanced-stage disease [16]. Surgery is currently the only golden
standard treatment for colorectal cancer with curative
potential [16,17]. However, curative surgery in most de-
veloping countries is limited due to the late presentation
in the majority of patients. Lack of adjuvant therapy in
most centers also poses a therapeutic challenge in
resource-limited countries.
Colorectal cancer is one of the cancers that can be pre-
vented by secondary prevention, which can be achieved by
screening tests that can detect pre-neoplastic lesions and
early cancer. Colorectal cancer screening programs in-
crease the detection of tumors at earlier stages and
reduce colorectal cancer incidence and mortality [18].
In resource-limited countries, however, lack of a screening
program poses a great challenge in the prevention of colo-
rectal cancer.
There is a paucity of information regarding colorectal
cancer in Tanzania and particularly the study area. This
is partly due to a lack of published local data regarding
this condition and lack of cancer registries in this region.
This study was designed to describe the clinicopatholog-
ical pattern of colorectal cancer and highlight the chal-
lenging problem in the management of this disease in
our local setting.Methods
Study design and setting
Between July 2006 and June 2011, a retrospective study
of histologically confirmed cases of colorectal cancer
was conducted at Bugando Medical Center. Bugando
Medical Center is a consultant and teaching hospital for
the Catholic University of Health and Allied Sciences-
Bugando (CUHAS-Bugando) in the Lake and Western
Zones of the United Republic of Tanzania. It is situated
along the shores of Lake Victoria in Mwanza City. It has
1000 beds and serves as a referral center for tertiary spe-
cialist care for a catchment population of approximately
13 million people. The hospital has a newly established
oncology department which provides care for all patients
with histopathologically proven cancers, including colo-
rectal cancers. However, the department does not pro-
vide radiotherapy services at the moment due to lack of
this facility at our center. As a result, patients requiring
this modality of treatment have to travel long distances
to receive radiotherapy at the Tanzania Tumor Center
located a considerable distance from the study area.Study population
The subjects of this study included all patients who
presented to Bugando Medical Centerwith histologically
confirmed colorectal cancer during the study period. Pa-
tients with incomplete data were excluded from the
study.
Table 1 Distribution of patients according to clinical
presentation
Clinical presentation Frequency Percentage
Rectal bleeding 180 54.2
Change in bowel habit 172 51.8
Abdominal pain 153 46.1
Constipation 140 42.2
Weight loss 122 36.7
Anemia 98 29.5
Abdominal mass 56 16.9
Feeling of incomplete evacuation 34 10.2
Anal mass 30 9.0
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files kept in the medical record department, the surgical
wards, operating theatre and histopathology laboratory.
Information retrieved included socio-demographic data,
clinical presentation, anatomical site, gross appearance,
tumor stage, histopathological type and grade, presence
of metastasis (nodal, distant and peritoneal), treatment
modalities and outcome and follow-up. The anatomical
site distributions were categorized as right colonic, left
colonic and rectal tumors. The tumor stage was
ascertained using the Tumor-Node-Metastases (TNM)
staging system of the International Union against
Cancer.
The diagnosis of colorectal cancer was performed by
barium enema, proctosigmoidoscopy and laparotomy
and confirmed histopathologically by endoscopic and
laparotomy biopsies. Baseline hemogram and stool mi-
croscopy, proctosigmoidoscopy, abdominal ultrasound,
liver function tests and chest radiographs were per-
formed routinely. Barium enema was performed only in
some patients. Carcinoembryonic antigen level was not
recorded in any patient. Colonoscopic examination was
also not performed due to its nonavailability. Treatment
modalities included surgery and adjuvant chemotherapy
and radiotherapy. Patients were followed up for up to 5
years or death. Survival analysis was carried out, with
survival defined as the time between the date of com-
mencement of treatment and the date of last follow-up
or death. The recurrence of disease was confirmed by
physical findings, radiological studies, endoscopic exam-
ination with biopsy, and surgery.
Definitions of variables
Right-sided: Lesions arising from the cecum, ascending
colon, hepatic flexure or transverse colon.
Left-sided: Lesions arising from splenic flexure, descend-
ing colon or sigmoid colon.
Dukes’ A: Growth confined to the wall
Dukes’B: Growth to the serosa and beyond, but no nodal
involvement




Data collected were analyzed using SPSS computer soft-
ware version 17.0 (SPSS, Inc., Chicago, IL, USA). Data
were summarized in the form of proportions and fre-
quency tables for categorical variables. Continuous vari-
ables were summarized using mean, median, mode and
standard deviation. Chi-square test was used to test for
significance of associations between the predictor and
outcome variables in the categorical variables. Student’s
t test was used to test for significance of associationsbetween the predictor and outcome variables in the con-
tinuous variables. Significance was defined as a Pvalue of
<0.05. Multivariate logistic regression analysis was used
to determine predictor variables that are associated with
outcome.
Ethical consideration
Ethical approval to conduct the study was sought from
the CUHAS-Bugando/Bugando Medical Center joint in-
stitutional ethic review committee before the com-
mencement of the study.
Results
Study population and demographic data
During the study period, a total of 7014 malignancies
were registered. Of these, 332 (4.7%) were histopatho-
logically confirmed colorectal cancer which formed the
study population. The number of males was 202 (60.8%)
and the number of females was 130 (39.2%) with a male
to female ratio of 1.6:1. The age ranged from 15 to 82
years with a median age of 46 years. The modal age
group at presentation was 41–50 years. One hundred
and twenty-seven (38.3%) patients were aged 40 years
and below. Family history of colorectal cancer was
reported in 18 (5.4%) cases. The majority of patients,
234(70.5%) came from the rural areas located a consider-
able distance from Mwanza City and most of them, 204
(61.4%), had either primary or no formal education.
Clinical presentation, anatomical sites, gross appearance,
histological patterns and tumor stage
The duration of symptoms at presentation ranged from
3 weeks to 7 years with a median duration of 22 months.
Two hundred and forty-two (72.9%) patients presented
within 6 months of onset and 90 (27.1%) presented lon-
ger than 6 months. Table 1 shows clinical presentation
of colorectal cancer patients.
There were 202 (60.8%) left-sided (distal colon) tu-
mors, 78 (23.5%) right-sided (proximal) tumors and 52
Table 3 Distribution of patients according to the type of
surgical procedures performed (N= 326)
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most frequent site for colorectal cancer in 182 (54.8%)
cases followed by cecum, ascending colon, descending
colon and transverse colon in 40 (12.0%), 25 (7.5%), 20
(6.0%) and13 (3.9%) cases, respectively. The anorectum
was involved in 52 (15.7%) cases. Of these, the tumor
was palpable on digital rectal examination in 48 (92.3%)
cases and in the remaining 4 (7.7%) patients the tumor
was accessible only by proctoscopic and sigmoidoscopic
examinations. There was no recorded cases of synchron-
ous or metachronous malignancies.
Macroscopically, the right-sided tumors were
fungating nodular lesions with surface ulcerations while
the left-sided tumors were flat and infiltrating or
constricting.
Microscopically, adenocarcinoma was the most com-
mon histopathological tumor in 328 (98.8%) patients.
The majority of adenocarcinomas were moderately dif-
ferentiated adenocarcinoma in 185(56.4%), 102 (31.1%)
were well-differentiated and 41(12.5%) were poorly dif-
ferentiated carcinoma. Mucinous and signet ring carcin-
omas accounted for 38 (11.6%) and 15 (4.6%) patients,
respectively. Seventeen (5.2%) were anaplastic (undiffer-
entiated) tumors. Mucinous carcinoma (9.1%) and signet
ring carcinoma (3.4%) were statistically significantly
more common in patients under 40 years, compared to
2.4% and 1.2% recorded in patients above 40 years, re-
spectively (P< 0.001). Mucinous adenocarcinomas were
statistically significantly more frequent in right-sided
(proximal) colon (9.8%) than in left-sided colon (1.8%)
(P =0.011). Mucinous adenocarcinomas and signet ring
carcinoma were significantly associated with a poor
prognosis compared to non- mucinous adenocarcinomas
(P< 0.001). Other histopathological tumors were non-
Hodgkin’s lymphoma, malignant gastrointestinal stromal
tumors, lieomyosarcoma and squamous cell carcinoma
in 1 (0.3%) patient each, respectively.
According to TNM staging, only 11 (3.3%) patients
were identified as being in early stages (TNM stage I)
and 321 (96.7%) patients were presented in advanced
stages (stage II-IV): Table 2 shows pathological staging
according to TNM staging. There were no statistically
significant differences between the right-sided and left-
sided colonic carcinoma regarding sex, age, histological






IV 82 (24.7)metastasis at the time of diagnosis was recorded in101
(30.4%) cases. Distant metastasis was recorded in 82
(24.7%) cases.
Diagnosis of colorectal cancer
The diagnosis of colorectal cancer was made by barium
enema and proctosigmoidoscopy in 111 (33.4%) and 98
(29.5%) patients, respectively. The remaining 123
(37.0%) patients were diagnosed during laparotomy for
other pathologies such as abdominal mass in 68 (55.3%)
patients, intestinal obstruction in 38(30.9%), intussuscep-
tion in 10(8.1%) and bowel perforation in 6 (4.9%) pa-
tients. No patients had colonoscopic examination.
Treatment modalities
Out of 332 patients, 326 (98.2%) patients underwent sur-
gical procedures for colorectal cancer and the remaining
6 (1.8%) patients were unfit for surgery. Of these 326,
282 (86.5%) patients were operated electively and the
remaining 44 (13.5%) were operated on an emergency
basis for intestinal obstruction in 38 (86.4%) and bowel
perforation with peritonitis in 6 (13.6%) patients. Left
hemicolectomy was the most frequent type of surgical
procedure performed, accounting for 58.6% of cases
(Table 3).
Adjuvant treatment (radiation therapy and/or chemo-
therapy) was indicated in 321 (96.7%) patients. Of these,
only 54 (16.8%) received adjuvant treatment. Out of 54
patients, 30 (9.3%) received chemotherapy, 23 (7.2%) re-
ceived radiotherapy and only 1 (0.3%) patient received
chemo-radiation therapy.
Treatment outcome and follow-up of patients
Postoperative complications were recorded in 86 (26.2%)
patients. Of these, surgical site infection was the most
common postoperative complication accounting for
41.9% of cases (Table 4). A total of 18 (5.5%) 5.5% = 18/
326 and not 18/321. patients required additional oper-
ation for perineal wound breakdown (8 patients)), intra-
abdominal abscess/peritonitis (8 patients) and anasto-
motic breakdown (2 patients).Surgical procedures performed Frequency Percentage
Left hemicolectomy 191 58.6
Right hemicolectomy 72 22.1
Abdomino-perineal resection 28 8.6
Transverse colectomy 12 3.7
Exploratory laparotomy + biopsy only 10 3.1
Anterior resection 8 2.5
Colostomy alone 5 1.5
Table 4 Distribution of patients according to
postoperative complications (N = 86)
Postoperative complications Frequency Percentage
Surgical site infections 36 41.9
Perianal wound breakdown 11 12.8
Intra-abdominal abscess/peritonitis 8 9.3
Anastomotic breakdown 5 5.8
Chest infections 5 5.8
Anemia 4 4.7
Septicemia 4 4.7
Renal failure 2 2.3
Deep venous thrombosis 1 1.2
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days with a median of 12 days. Patients who developed
postoperative complications and those who had
abdomino-perineal resection had a longer hospital stay
(P< 0.001).
Out of 332 patients, 297 (89.5%) were alive. Thirty-five
patients died in hospital giving a mortality rate of 10.5%.
Of those who were alive, 264(88.9%) were discharged
well and the remaining 33 (11.1%) were discharged with
permanent colostomy.
Follow-up of patients among survivors ranged from 3
to 61 months with a median of 18 months. At the end of
3 months, 6 months, 2 years and 5 years, 45(15.2%), 34
(11.4%), 15 (5.1%) and 9 (3.0%) patients (survivors), res-
pectively, were available for follow-up. Cancer recurrence
was reported in 56 (18.9%) patients. Data on long-term
survivals were not available as the majority of patients
were lost to follow-up.
Discussion
In this review, colorectal cancer accounted for 4.7% of
all diagnosed malignancies seen during the study period
in our setting. This concurs with figures of 3.7 to 10%
that have been reported from various parts of Africa
[15,17,19-21]. There is a marked variation in the inci-
dence of colorectal cancer worldwide, with western
countries having a high rate compared to Africa [1,3,4].
However, a rising incidence of colorectal cancer has
been reported from various parts of Africa which were
considered low incidence areas [11-13,20]. This rising
incidence of colorectal cancer in Africa has been attrib-
uted to improved cancer awareness and a shift towards a
western diet.
As reported in other African studies [11-13], the me-
dian age of 46 years in this study was younger than the
age described in most developed countries; about 10
years difference has been reported in these studies. In
this study, 38.3% of colorectal cancer patients were
found to be below the age of 40 years, a figure which ishigher than the figure of 2 to 6% reported in western
countries [22,23]. Higher figures of colorectal cancer pa-
tients aged below the age of 40 years were also reported
in other studies [5,12]. In the African population, colo-
rectal cancer tends to be more aggressive and occurs at
a relatively young age at the time of presentation. Colo-
rectal cancer in the younger age group has been shown
to present a diagnostic and therapeutic problem and
prognosis tends to be less favorable [14]. The presence
of a high number of young patients with colorectal can-
cer in low-risk communities necessitates family screen-
ing since genetic factors may play an important role in
the development of this disease. This makes early detec-
tion and management an important measure in order to
reduce incidence and mortality.
The male predominance demonstrated in this study
was in keeping with previous observations reported in
studies performed elsewhere [11,24-26]. We could not
establish the reason for the male predominance.
In this study, a family history of colorectal cancer was
reported in 5.4% of cases, a figure which is slightly
higher than 4.3% reported by Azadeh et al. [27] in Iran.
This suggests that genetic factors may be playing an im-
portant role in the development of this disease in our
country. Based on this alarming observation we suggest
that screening programs, especially genetic screening
programs, should be considered as a main measure for
prevention and control of colorectal cancer in this part
of the world.
In keeping with other studies performed in developing
countries [12,15,17,21,24,26], the majority of patients in
this series came from the rural areas located a consider-
able distance from the study area and more than 60%
had either primary or no formal education. This obser-
vation has an implication on accessibility to healthcare
facilities and awareness of the disease.
In the present study, the majority of patients pre-
sented late with advanced stage of cancer which is in
keeping with other studies in developing countries
[5,11-15,28-30]. Late presentation in our study may
be attributed to lack of awareness of the disease, low
standard of education, lack of accessibility to health-
care facilities and lack of screening programs in this
region. Late presentation of cases is an area of colorectal
cancer care in our center that requires urgent attention.
There needs to be an increased awareness of the symp-
toms of colorectal cancer in the general population, along
with implementation of screening programs in this region.
Detecting colorectal cancer at an early stage contributes
to improved chances for successful treatment and thus
for survival.
Rectal bleeding was the commonest symptom for colo-
rectal cancer in the current study which is in agreement
with other studies reported in developing countries
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prompts patients to seek medical help. It remains a
diagnostic challenge, on the basis of bleeding alone, to
distinguish a benign anal condition from a serious un-
derlying colorectal disease. Bleeding is the index symp-
tom in early stage colorectal cancer and merits urgent
and full investigation [31]. High rectal bleeding rate
among patients with colorectal cancer in the present
study may be attributed to the large number of patients
with left-sided tumors, particularly the rectosigmoid and
anorectal tumors. Previous studies have, however, indi-
cated that rectal bleeding can reasonably predict colo-
rectal cancer, especially when reported in older patients
and in combination with a change in bowel habits or ab-
dominal pain [33,34].It would appear, therefore, that it
may be worth investigating rectal bleeding in all cases.
Early colorectal investigations for the patients with rectal
bleeding, change of bowel habits and anemia may im-
prove the outlook.
Regarding the anatomical location of colorectal cancer
at presentation, there was a preponderance of left-sided
tumors, especially rectosigmoid, in this study as reported
by others in developing countries [12-14,31,32,35,36].
This contrasts with the right-side preponderance (prox-
imal shift) reported in developed countries [37,38]. The
reason for this anatomical difference among these coun-
tries is not clear.
Macroscopically, the left-sided tumors were flat and
infiltrating or constricting whereas the right-sided tu-
mors were fungating nodular lesions with surface ulcera-
tions. This observation concurs with Abdulkareem et al.
[39] in Nigeria. Tumors on the right side (ascending
colon and cecum) tend to be exophytic; that is, the
tumor grows outwards from one location in the bowel
wall. This very rarely causes obstruction of feces, and
presents with symptoms such as anemia. Left-sided tu-
mors tend to be circumferential, and can obstruct the
bowel much like a napkin ring [39].
Microscopically, approximately 95% of colorectal can-
cers are adenocarcinomas arising from the epithelial
lining of the colorectum [40]. In this study, adenocar-
cinoma was the most frequent (98.8%) with moderately
differentiated tumors accounting for more than 50% of
cases. This finding is in agreement with Missaoui et al.
[41] in Tunisia who reported similar histopathological
patterns. Other histopathological tumors in the present
study were non-Hodgkin’s lymphoma, malignant gas-
trointestinal stromal tumors, lieomyosarcoma and squa-
mous cell carcinoma. The present study also showed
that patients <40 years of age tended to have poor prog-
nostic tumors such as mucinous and signet ring carcin-
oma. This finding concurs with Fazeli et al. [25] in Iran
who reported that 22% of patients less than 40 years of
age had poorly differentiated tumor compared to 5.9% inpatients above 40 years of age. Mucinous carcinomas
have been associated with poor prognosis with poor
response to chemotherapy and tend to be located in
the proximal colon and associated with microsatellite
instability [42].
According to TNM staging, more than 90% of pa-
tients in this series presented with advanced stages and
only 3.3% of cases presented with early-stage cancer.
This finding concurs with most reports from Africa
[15,25,26,43,44]. This can be attributed mainly to the
absence of specific screening measures for colorectal
cancer among the Tanzanian population. There is consi-
derable evidence that screening of asymptomatic persons
who are at average risk can detect cancers at an early
and curable stage, resulting in a reduction in mortality
[18]. Furthermore, some screening tests may also detect
cancer-precursor lesions, which, if removed, may result
in a reduced incidence of colorectal cancer [45].
In this study, lymph node and distant metastases at
the time of diagnosis were recorded in 30.4% and 24.7%
of cases respectively. A similar metastatic pattern was
reported by Yawe et al. [32] in Nigeria. High lymph node
and distant metastases in this study is attributed to the
late presentation in the majority of patients and this
confirmed the highly metastatic potential of colorectal
cancer.
The diagnosis of colorectal cancer in our series was
made on the basis of digital rectal examination, barium
enema and proctosigmoidoscopy, and the majority of pa-
tients were diagnosed during laparotomy for other path-
ologies such as abdominal mass, intestinal obstruction,
intussusception and bowel perforation. In this study, no
patient had colonoscopy due to the lack of this facility at
our center. A similar diagnostic pattern was reported in
most African centers [15,25,26,32]. Lack of colonoscopy
at our center remains a major challenge in the manage-
ment of colorectal cancer as early recognition of symp-
tomatic colorectal cancer can be a challenge for the
physician, resulting in a delay in the start of appropriate
treatment.
The treatment of colorectal cancer requires a multidis-
ciplinary approach. Treatment modalities of colorectal
cancer include surgery combined with chemotherapy
and radiotherapy given either as neo or adjuvant therapy
[16]. Surgery continues to be the primary treatment op-
tion for colorectal cancer patients and colon/rectal re-
section has been the standard procedure for cancer
primarily localized in the colon/rectum [16,17].
Complete resection of colorectal cancer with resection
of adjacent lymph node is the only chance for cure in
early-stage cancer [16,17,32]. However, most of the pa-
tients we see in our environment present late with ad-
vanced disease at the time of diagnosis, for which only
palliative surgery is possible. In this study, only 3.3% of
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tent which is in agreement with other studies in devel-
oping countries [15,25,26,43,44]. The low resection rate
of colorectal cancer with “curative” intent in our series
could be explained by the high proportion of patients
with advanced colorectal cancer at presentation. Al-
though anorectal cancer was diagnosed in 52 patients,
only 28 (50%) patients had abdomino-perineal resection
and end-colostomy. Five patients with advanced anorec-
tal cancer had colostomy alone. Sphincter saving surgery
was not practicable as lesions were not only too low but
also advanced. This observation can be explained by the
fact that the majority of our patients presented late with
features of advanced disease, as similarly reported by
Yawe etal. [32]. This late presentation still poses a chal-
lenge to management of colorectal cancer in our setting
and requires public education.
Despite the fact that surgery is the main stay of treat-
ment, radiotherapy and chemotherapy play a vital role,
particularly in locally advanced colorectal tumor [16].
The majority of patients with colorectal cancer in this
study had advanced stage of the disease at presentation
and were therefore candidates for this form of treatment.
In the present study, only 9.3% of patients received
chemotherapy despite the establishment of an onco-
logical unit in our center in 2009. In resource poor
countries such as Tanzania, nonadherence to chemother-
apy is a major challenge in cancer treatment including
colorectal cancer. Reasons for nonadherence in most de-
veloping countries include financial difficulty, resorting
to alternative treatment and drug side effects [32]. We
could not establish the reasons for nonadherence to
chemotherapy in our study due to the retrospective na-
ture of the study. Further prospective study is needed to
explain this observation.
Radiation therapy has been shown to improve local
control rates in locally advanced colorectal cancers when
applied preoperatively or postoperatively. However, in
our study only 7.2% of patients who required radiother-
apy had access to this form of treatment. This concurs
with other studies in resourcelimited countries [32,46].
Failure to access this modality of treatment in our pa-
tients can be explained by the fact that radiotherapy is
not available in our center and therefore patients requir-
ing this form of treatment had to travel long distances to
receive radiotherapy at the oncological center. This sad
observation calls for urgent establishment of radiother-
apy services in our center.
In this study, postoperative complications were
recorded in 26.2% which is higher than that of 12.6%
reported by Datubo et al. [47] in Ghana. The higher
complication rate in this study is attributed to late pres-
entation and delayed definitive treatment. Additional
operations were required in 5.5% of patients whodeveloped postoperative complications such as perianal
wound breakdown, intra-abdominal abscesses, periton-
itis and anastomotic leak. These required additional op-
erations that are associated with a prolonged hospital
stay and cost of treatment. An improvement in surgical
technique is therefore crucial to lower the occurrence of
these postoperative complications while their prompt
recognition and treatment would reduce the attendant
mortality.
The median duration of hospital stay in our study was
12 days, which is higher than that reported in other
studies [32,47]. This can be explained by a high rate of
postoperative complications which required additional
operations/care and subsequently prolonged hospital
stay. Also, patients who had abdomino-perineal resec-
tion had a longer hospital stay. Prolonged duration of
hospital stay has an impact on hospital resources as well
as on increased cost of healthcare, loss of productivity
and reduced quality of life.
Our overall mortality rate in the present study was
10.5%, a figure that is higher than 6.1% reported by
Datubo et al. [47] in Ghana. The high mortality rate in
our study may be attributed to the fact that most pa-
tients presented late with advanced stage.
The follow-up of patients in this study was generally
poor, and data on long-term survival were not available.
This observation concurs with Yawe et al. [32] in
Nigeria. Poor follow-up of patients in our study may be
explained by the fact that the majority of patients were
lost to follow-up at the end of 5years.
The potential limitation of this study is the fact that
information about some patients was incomplete in view
of the retrospective nature of the study and this might
have introduced some bias in our findings. Also, this
study included only patients who were evaluated and
treated at a single institution, which may not reflect the
whole population in this region, despite the fact that ap-
proximately 70% of oncologic patients in northwestern
Tanzania are managed at our center. However, despite
this limitation, the study has provided local data that can
help healthcare providers in the management of patients
with colorectal cancer. The challenges identified in the
management of colorectal cancer in our setting need to
be addressed in order to deliver optimal care for these
patients.
Conclusions
Compared to data from western countries, colorectal
cancer in this environment shows a trend towards rela-
tive young age at diagnosis and the majority of patients
present late with advanced stage. Lack of awareness of
the disease, poor accessibility to healthcare facilities, lack
of diagnostic facilities, lack of screening programs, poor
accessibility to adjuvant therapy, the high cost of care
Chalya et al. World Journal of Surgical Oncology 2013, 11:88 Page 8 of 9
http://www.wjso.com/content/11/1/88and a high morbidity and mortality are among the hall-
marks of the disease in this region and pose a great chal-
lenge in the management of these patients. Therefore,
public enlightenment, screening of high-risk popula-
tions, early diagnosis, and effective cost-effective treat-
ment and follow-up will help reverse this trend.
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